3-Week Database Builds That Withstood FDA Review

Scaling a clinical program with a three-person operations team sounds nearly impossible, yet the biotechnology firm Gameto managed nine concurrent global studies across four continents while maintaining rigorous regulatory standards. By utilizing Castor's centralized electronic data capture (EDC) system, the team functioned as their own data management unit, bypassing the friction often associated with large CROs. This lean approach proved essential for their Fertilo system—an ex vivo egg-maturation technology designed to make IVF safer and more effective.

The project faced severe hurdles, including the need to deploy regulator-ready databases in just three weeks and the complex requirement of tracking longitudinal safety data. By integrating high-resolution remote source document verification and synthetic control arms, they built a pristine, 38-patient dataset entirely outside the US. This data was so robust that it secured FDA IND clearance for immediate Phase 3 entry. These insights demonstrate how flexibility and internal oversight can overcome extreme resource constraints to deliver high-quality, audit-ready results on an aggressive timeline.